MAPT and Alzheimer disease: Both of these genes were significantly upregulated in AD brains in the pericyte cl.25 and had strong interactions with astrocyte ligands, some of which are known AD risk genes, namely APOE, APP, PSEN1 and MAPT, previously shown to lead to BBB dysfunction in model systems92.